Previous close | 43.38 |
Open | 43.38 |
Bid | 43.10 |
Ask | 44.10 |
Strike | 180.00 |
Expiry date | 2023-11-17 |
Day's range | 43.38 - 43.38 |
Contract range | N/A |
Volume | |
Open interest | 5 |
The European Commission approves AbbVie's (ABBV) Tepkinly (epcoritamab) for DLBCL. FDA approves Lilly's (LLY) Jardiance for chronic kidney disease.
Zacks.com users have recently been watching AbbVie (ABBV) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Oracle, AbbVie, Lowe's Companies, Ecolab and Motorola Solutions are part of the Zacks top Analyst Blog .